Name: Atea Pharmaceuticals, Inc. (AVIR) Balance Sheet
Creator: FinSpry

Atea Pharmaceuticals Balance Sheet Analysis

Assets, liabilities, and stockholders equity in millions USD

Scale:

Scroll to see more

Balance sheet showing assets, liabilities, and shareholders' equity for Atea Pharmaceuticals, Inc. (AVIR) - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Current Assets
Cash and Cash Equivalents	64.70	578.11	188.46	764.38	850.12
Short-Term Investments	390.03	434.28	458.25	0.00	0.00
Cash & Short-Term Investments	454.72	578.11	646.71	764.38	850.12
Accounts Receivable	0.00	5.90	0.00	0.00	5.82
Inventory	0.00	0.00	0.00	0.00	0.00
Other Current Assets	7.63	5.76	14.21	8.03	7.55
Total Current Assets	462.36	590.46	660.92	772.40	863.48
Non-Current Assets
Property, Plant & Equipment (Net)	2.12	3.12	4.09	0.18	0.05
Other Non-Current Assets	0.20	1.40	1.69	0.31	0.11
Total Non-Current Assets	2.31	4.51	5.79	0.49	0.16
Total Assets	464.67	594.97	666.71	772.89	863.63
Current Liabilities
Accounts Payable	4.46	31.62	2.55	4.53	0.06
Short-Term Debt	0.80	0.00	0.00	0.00	0.00
Accrued Liabilities	13.35	27.36	15.11	24.58	14.37
Deferred Revenue	0.00	0.00	0.00	0.00	301.37
Other Current Liabilities	13.35	5.70	6.46	25.00	2.74
Total Current Liabilities	18.60	32.38	18.48	56.88	315.80
Non-Current Liabilities
Long-Term Debt	0.84	1.64	2.40	0.00	0.00
Other Non-Current Liabilities	6.36	5.76	5.26	5.93	0.04
Total Non-Current Liabilities	7.20	7.40	7.66	5.93	0.04
Total Liabilities	25.80	39.78	26.14	62.82	315.83
Stockholders' Equity
Common Stock	0.08	0.08	0.08	0.08	0.08
Retained Earnings	-364.22	-195.63	-59.88	56.03	-65.16
Accumulated Other Comprehensive Income	0.23	0.21	-0.68	0.00	0.00
Additional Paid-in Capital	802.77	750.74	701.05	653.96	612.88
Shares Outstanding	84.46	83.44	83.29	83.10	0.00
Total Stockholders' Equity	438.87	555.19	640.57	710.08	547.80
Total Liabilities & Equity	464.67	594.97	666.71	772.89	863.63